Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Sprout Pharms drug ADDYI appeared first on Drug…
New patent expiration for Sprout Pharms drug ADDYI Read Post »
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Indivior Inc drug SUBOXONE appeared firs…
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug…
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug…
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug…
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
Annual Drug Patent Expirations for AVANDAMET Avandamet is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting this drug and one Paragraph…
The post New patent expiration for Sb Pharmco drug AVANDAMET appeared first …
New patent expiration for Sb Pharmco drug AVANDAMET Read Post »
Annual Drug Patent Expirations for MICARDIS Micardis is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There is one patent…
The post New patent expiration for Boehringer Ingelheim drug MICARDIS a…
New patent expiration for Boehringer Ingelheim drug MICARDIS Read Post »
Annual Drug Patent Expirations for TRINTELLIX Trintellix is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from three suppliers. There are ten…
The post New patent expiration for Takeda Pharms drug TRINTELLIX appeared …
New patent expiration for Takeda Pharms drug TRINTELLIX Read Post »
Annual Drug Patent Expirations for TRINTELLIX Trintellix is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from three suppliers. There are ten…
The post New patent expiration for Takeda Pharms drug TRINTELLIX appeared …
New patent expiration for Takeda Pharms drug TRINTELLIX Read Post »
ABILIFY (aripiprazole) Otsuka Patent: 9,359,302 Expiration: Sep 25, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
Drug Patent Expirations for the Week of September 25, 2022 Read Post »